• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者脑脊液中谷氨酰胺合成酶的检测:一种潜在的诊断生化标志物。

Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker.

作者信息

Gunnersen D, Haley B

机构信息

Department of Biochemistry, College of Pharmacy, University of Kentucky, Lexington 40536-0084.

出版信息

Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11949-53. doi: 10.1073/pnas.89.24.11949.

DOI:10.1073/pnas.89.24.11949
PMID:1361232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC50675/
Abstract

In this report, 8- and 2-azidoadenosine 5'-[gamma-32P]triphosphate were used to examine cerebrospinal fluid (CSF) samples for the presence of an ATP binding protein unique to individuals with Alzheimer disease (AD). A 42-kDa ATP binding protein was found in the CSF of AD patients that is not observed in CSF from normal patients or other neurological controls. The photolabeling is saturated with 30 microM 2-azidoadenosine 5'-[gamma-32P]triphosphate. Photoinsertion can be totally prevented by the addition of 25 microM ATP. Photoinsertion of 2-azidoadenosine 5'-triphosphate into the protein is only weakly protected by other nucleotides such as ADP and GTP, indicating that this is a specific ATP binding protein. A total of 83 CSF samples were examined in a blind manner. The 42-kDa protein was detected in 38 of 39 AD CSF samples and in only 1 of 44 control samples. This protein was identified as glutamine synthetase [GS; glutamate-ammonia ligase; L-glutamate:ammonia ligase (ADP-forming), EC 6.3.1.2] based on similar nucleotide binding properties, comigration on two-dimensional gels, reaction with a polyclonal anti-GS antibody, and the presence of significant GS enzyme activity in AD CSF. In brain, GS plays a key role in elimination of free ammonia and also converts the neurotransmitter and excitotoxic amino acid glutamate to glutamine, which is not neurotoxic. The involvement of GS, if any, in the onset of AD is unknown. However, the presence of GS in the CSF of terminal AD patients suggests that this enzyme may be a useful diagnostic marker and that further study is warranted to determine any possible role for glutamate metabolism in the pathology of AD.

摘要

在本报告中,使用8 - 叠氮腺苷5'-[γ-32P]三磷酸和2 - 叠氮腺苷5'-[γ-32P]三磷酸来检测脑脊液(CSF)样本,以确定阿尔茨海默病(AD)患者所特有的一种ATP结合蛋白的存在情况。在AD患者的脑脊液中发现了一种42 kDa的ATP结合蛋白,而在正常患者或其他神经学对照的脑脊液中未观察到。用30 microM 2 - 叠氮腺苷5'-[γ-32P]三磷酸时光标记达到饱和。加入25 microM ATP可完全阻止光插入。2 - 叠氮腺苷5'-三磷酸插入该蛋白的过程仅受到其他核苷酸如ADP和GTP的微弱保护,表明这是一种特异性的ATP结合蛋白。以盲法检测了总共83份脑脊液样本。在39份AD脑脊液样本中的38份以及44份对照样本中的1份中检测到了这种42 kDa的蛋白。基于相似的核苷酸结合特性、在二维凝胶上的共迁移、与多克隆抗GS抗体的反应以及AD脑脊液中存在显著的GS酶活性,该蛋白被鉴定为谷氨酰胺合成酶[GS;谷氨酸 - 氨连接酶;L - 谷氨酸:氨连接酶(形成ADP),EC 6.3.1.2]。在大脑中,GS在清除游离氨方面起关键作用,还将神经递质和具有兴奋性毒性的氨基酸谷氨酸转化为无神经毒性的谷氨酰胺。GS在AD发病过程中(若有)的作用尚不清楚。然而,晚期AD患者脑脊液中存在GS表明该酶可能是一种有用的诊断标志物,有必要进一步研究以确定谷氨酸代谢在AD病理过程中的任何可能作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e12e/50675/8711bdc4b327/pnas01098-0313-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e12e/50675/9685bc617e08/pnas01098-0312-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e12e/50675/8711bdc4b327/pnas01098-0313-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e12e/50675/9685bc617e08/pnas01098-0312-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e12e/50675/8711bdc4b327/pnas01098-0313-a.jpg

相似文献

1
Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker.阿尔茨海默病患者脑脊液中谷氨酰胺合成酶的检测:一种潜在的诊断生化标志物。
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11949-53. doi: 10.1073/pnas.89.24.11949.
2
Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?脑脊液、血清和大脑中的谷氨酰胺合成酶:阿尔茨海默病的诊断标志物?
Arch Neurol. 1999 Oct;56(10):1241-6. doi: 10.1001/archneur.56.10.1241.
3
Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer's disease patients are unchanged.阿尔茨海默病患者脑脊液中谷氨酰胺合成酶的总水平未发生变化。
Neurobiol Aging. 2015 Mar;36(3):1271-3. doi: 10.1016/j.neurobiolaging.2014.12.010. Epub 2014 Dec 12.
4
Discovery of the ammonium substrate site on glutamine synthetase, a third cation binding site.谷氨酰胺合成酶上铵离子底物位点的发现,即第三个阳离子结合位点。
Protein Sci. 1995 Nov;4(11):2358-65. doi: 10.1002/pro.5560041114.
5
YbdK is a carboxylate-amine ligase with a gamma-glutamyl:Cysteine ligase activity: crystal structure and enzymatic assays.YbdK是一种具有γ-谷氨酰半胱氨酸连接酶活性的羧酸-胺连接酶:晶体结构与酶活性测定
Proteins. 2004 Aug 1;56(2):376-83. doi: 10.1002/prot.20103.
6
Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol.联合酸化和中和方案优化脑脊液中谷氨酰胺合成酶和髓鞘碱性蛋白的定量分析。
J Immunol Methods. 2012 Jul 31;381(1-2):1-8. doi: 10.1016/j.jim.2012.04.001. Epub 2012 Apr 19.
7
Molecular Mechanisms of Glutamine Synthetase Mutations that Lead to Clinically Relevant Pathologies.导致临床相关病理的谷氨酰胺合成酶突变的分子机制。
PLoS Comput Biol. 2016 Feb 2;12(2):e1004693. doi: 10.1371/journal.pcbi.1004693. eCollection 2016 Feb.
8
Regulation of glutamine synthetase activity by adenylylation in the Gram-positive bacterium Streptomyces cattleya.革兰氏阳性菌卡特利链霉菌中腺苷酰化对谷氨酰胺合成酶活性的调控。
Proc Natl Acad Sci U S A. 1981 Jan;78(1):229-33. doi: 10.1073/pnas.78.1.229.
9
Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.哺乳动物谷氨酰胺合成酶的晶体结构阐明了底物诱导的构象变化,并为药物和除草剂设计提供了机会。
J Mol Biol. 2008 Jan 4;375(1):217-28. doi: 10.1016/j.jmb.2007.10.029. Epub 2007 Oct 17.
10
Purification and some properties of glutamate dehydrogenase and glutamine synthetase from Paracoccus denitrificans.反硝化副球菌谷氨酸脱氢酶和谷氨酰胺合成酶的纯化及某些性质
J Gen Microbiol. 1992 Aug;138 Pt 8:1587-91. doi: 10.1099/00221287-138-8-1587.

引用本文的文献

1
Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis.阿尔茨海默病中谷氨酸能和γ-氨基丁酸能代谢物水平:一项系统评价和荟萃分析。
BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.
2
Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases.氧化应激:慢性神经退行性疾病的病理驱动因素
Antioxidants (Basel). 2025 Jun 9;14(6):696. doi: 10.3390/antiox14060696.
3
Toward structural-omics of the bovine retinal pigment epithelium.朝向牛视网膜色素上皮的结构组学研究。

本文引用的文献

1
SYNTHESIS OF NUCLEOTIDE ANHYDRIDES BY ANION EXCHANGE.通过阴离子交换合成核苷酸酐。
Biochim Biophys Acta. 1964 Sep 11;91:1-13. doi: 10.1016/0926-6550(64)90164-1.
2
Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations.痴呆患者脑脊液微量元素含量:临床、影像学及病理学相关性研究
Neurology. 1983 Oct;33(10):1350-3. doi: 10.1212/wnl.33.10.1350.
3
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
Cell Rep. 2022 Dec 27;41(13):111876. doi: 10.1016/j.celrep.2022.111876.
4
A cryo-electron microscopic approach to elucidate protein structures from human brain microsomes.一种利用低温电子显微镜技术从人脑微粒体中阐明蛋白质结构的方法。
Life Sci Alliance. 2022 Nov 30;6(2). doi: 10.26508/lsa.202201724. Print 2023 Feb.
5
Glial Glutamine Homeostasis in Health and Disease.健康与疾病中的胶质谷氨酰胺稳态
Neurochem Res. 2023 Apr;48(4):1100-1128. doi: 10.1007/s11064-022-03771-1. Epub 2022 Nov 2.
6
USP15 antagonizes CRL4-mediated ubiquitylation of glutamine synthetase and neosubstrates.USP15 拮抗 CRL4 介导的谷氨酰胺合成酶及其新底物的泛素化。
Proc Natl Acad Sci U S A. 2021 Oct 5;118(40). doi: 10.1073/pnas.2111391118.
7
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.高效液相色谱法测定阿尔茨海默病患者脑、脑脊液和血清中 L-谷氨酸、L-谷氨酰胺和甘氨酸的含量。
Amino Acids. 2021 Mar;53(3):435-449. doi: 10.1007/s00726-021-02943-7. Epub 2021 Feb 22.
8
Structural Insight into the Contributions of the N-Terminus and Key Active-Site Residues to the Catalytic Efficiency of Glutamine Synthetase 2.谷氨酰胺合成酶2的N端和关键活性位点残基对催化效率贡献的结构洞察
Biomolecules. 2020 Dec 14;10(12):1671. doi: 10.3390/biom10121671.
9
Impairment of motor coordination and interneuron migration in perinatal exposure to glufosinate-ammonium.围产期接触草铵膦会损害运动协调和中间神经元迁移。
Sci Rep. 2020 Nov 26;10(1):20647. doi: 10.1038/s41598-020-76869-7.
10
Deciphering the Astrocyte Reaction in Alzheimer's Disease.解读阿尔茨海默病中的星形胶质细胞反应
Front Aging Neurosci. 2018 Apr 25;10:114. doi: 10.3389/fnagi.2018.00114. eCollection 2018.
阿尔茨海默病的临床诊断:美国国立神经疾病与中风研究所-阿尔茨海默病及相关疾病协会工作组在卫生与公众服务部阿尔茨海默病特别工作组主持下的报告。
Neurology. 1984 Jul;34(7):939-44. doi: 10.1212/wnl.34.7.939.
4
Photoaffinity labeling of nucleotide binding sites with 8-azidopurine analogs: techniques and applications.用8-叠氮嘌呤类似物对核苷酸结合位点进行光亲和标记:技术与应用
Methods Enzymol. 1983;91:613-33. doi: 10.1016/s0076-6879(83)91054-6.
5
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
6
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.阿尔茨海默病新皮质病理变化分布的解剖学关联
Proc Natl Acad Sci U S A. 1985 Jul;82(13):4531-4. doi: 10.1073/pnas.82.13.4531.
7
Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease.阿尔茨海默病患者大脑中的氨基酸、谷胱甘肽及谷胱甘肽转移酶活性
Ann Neurol. 1987 Apr;21(4):331-6. doi: 10.1002/ana.410210403.
8
Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.阿尔茨海默病中谷氨酸能去神经支配及可能的异常代谢证据。
J Neurochem. 1988 Mar;50(3):790-802. doi: 10.1111/j.1471-4159.1988.tb02983.x.
9
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.阿尔茨海默病细胞骨架病理学中微管相关蛋白tau(tau)的异常磷酸化。
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7. doi: 10.1073/pnas.83.13.4913.
10
Biochemistry and physiology of brain ammonia.脑氨的生物化学与生理学
Physiol Rev. 1987 Apr;67(2):440-519. doi: 10.1152/physrev.1987.67.2.440.